Find uplifting stories about heroes, innovations, and solutions
1316 results for "chronic urticaria"
A newly approved oral medication is giving hope to adults with chronic spontaneous urticaria, a condition that causes relentless itching so severe some patients can't sleep. One-third of patients achieved complete symptom relief within 12 weeks.
A Buddhist meditation teacher who developed chronic illness from black mold exposure discovered how mindfulness and hypnosis can rewire the brain to help people suffering from ongoing health conditions. Her personal journey is now helping others find hope and healing.
Scientists discovered a brain circuit that drives chronic pain separately from protective acute pain, opening the door to treatments that could help 60 million Americans without dulling their danger responses. When researchers silenced this circuit in mice, chronic pain disappeared while normal pain signals stayed intact.
For 50 million Americans living with chronic pain that drugs can't touch, Virginia Tech researchers just delivered groundbreaking news: they've reversed persistent pain in mice by targeting a previously overlooked biological pathway. The discovery could lead to the first new non-opioid chronic pain treatment in years.
A small clinical trial reveals that ketamine, already used for depression, may offer rapid energy relief to millions suffering from chronic fatigue. The findings give hope to patients who've exhausted all other options.
Scientists discovered that intermittent fasting not only reduces chronic pain but also eases the anxiety and depression that often come with it. The breakthrough could lead to new treatments that tackle both problems at once.
Virginia Tech researchers have successfully reversed chronic pain in mice by blocking a single enzyme pathway, offering hope for 50 million Americans whose pain doesn't respond to current treatments. The breakthrough targets a biological mechanism previously overlooked by conventional painkillers.
Medicare is expanding a groundbreaking program that pays healthcare companies to actually improve patient outcomes, not just provide services. The ACCESS model now covers 10 chronic conditions affecting three out of four Medicare beneficiaries.
Researchers have identified the genetic fingerprint of "sleeping" pain neurons that affect 10% of people with chronic nerve pain. This breakthrough opens the door to targeted treatments that could silence overactive pain signals without affecting normal sensation.
Researchers discovered a natural pain control switch in the brain that could lead to safer treatments for millions suffering from chronic nerve pain. The finding offers hope for relief without the risks of traditional opioid medications.
A supplement already sitting in millions of medicine cabinets might work as well as prescription painkillers for chronic pain. University of Sydney researchers found melatonin reduced pain by the same amount as opioids and NSAIDs in over 2,000 patients.
People with long Covid, POTS, and other chronic conditions are using fitness trackers to avoid debilitating crashes and reclaim their lives. After three years of tracking her health data, one journalist went from bedridden episodes to living crash-free.
A Brazilian study found that ear acupuncture helped reduce migraine pain by up to 18% in women suffering from chronic attacks. The research offers hope for the millions who struggle to find relief from conventional treatments alone.
More than 150 digital health companies just got the green light to help millions of Medicare patients manage chronic conditions like diabetes and depression. Most have never served Medicare patients before, marking a huge shift in how seniors access care.
As chronic illnesses surge across Uganda, health experts are calling for physiotherapy to become a standard part of treatment, not an afterthought. The shift could help thousands regain mobility and independence while reducing long-term healthcare costs.
A groundbreaking Medicare program will pay healthcare providers based on whether patients actually get healthier, not just for services delivered. Health tech company Cadence is among the first to join the experiment that could transform how chronic disease care works in America.
Scientists at Virginia Tech have reversed chronic pain in mice by blocking a single enzyme pathway, offering hope for 50 million Americans whose pain doesn't respond to current treatments. The discovery could lead to the first new class of non-opioid pain relief in years.
Nearly 2 million Africans die prematurely each year from hypertension and diabetes complications, but a new continental program is transforming how health systems respond. Africa CDC just launched SPARK-NCD, integrating chronic disease care into existing platforms to save lives across the continent.
Scientists at MD Anderson Cancer Center discovered that a protein linked to cancer also drives chronic nerve pain, and existing cancer drugs reduced pain in early tests. The finding could fast-track new treatments for millions suffering nerve damage pain that doesn't respond to current medications.
Scientists discovered that intermittent fasting could help manage chronic pain by changing how the gut and brain communicate. The breakthrough offers hope for millions living with pain lasting longer than three months.
Showing 20 of 1316